Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Rinvoq (upadacitinib) and Cosentyx (secukinumab) are both medications used to treat inflammatory conditions like ankylosing spondylitis and psoriatic arthritis. However, they belong to different medication classes. Rinvoq is a Janus kinase (JAK) inhibitor, while Cosentyx is an interleukin 17 (IL-17) inhibitor. Rinvoq is taken orally, either as a tablet or liquid, and is typically dosed once daily. In contrast, Cosentyx is administered as an injection, usually once a month after initial loading doses. Both medications are only available as brand-name products. Common side effects of Rinvoq include acne and upper respiratory infections, while Cosentyx may cause common cold symptoms and diarrhea. Both medications can increase the risk of infections, but Cosentyx may also worsen inflammatory bowel disease symptoms. Additionally, Rinvoq interacts with grapefruit, while Cosentyx requires caution with latex allergies due to its injection devices.
Rinvoq (upadacitinib)
Cosentyx (secukinumab)
Rinvoq (upadacitinib)
Cosentyx (secukinumab)
Summary of Rinvoq vs. Cosentyx
Summary for JAK inhibitor
Prescription only
Rinvoq (upadacitinib) is a Janus kinase (JAK) inhibitor. It's used to treat certain inflammatory conditions, such as rheumatoid arthritis (RA), ulcerative colitis (UC), and eczema (atopic dermatitis). But it's not a first-choice option and typically only prescribed when other treatments haven't worked well. Rinvoq (upadacitinib) is taken by mouth, usually once daily. It's available as an extended-release tablet (Rinvoq) and an oral solution (Rinvoq LQ), but the two formulations aren't interchangeable. Side effects include a higher risk of infections, acne, and nausea.
Summary for Interleukin 17 (IL-17) antagonist
Prescription only
Cosentyx (secukinumab) is an injectable medication that helps treat many inflammatory conditions. This includes psoriatic arthritis (PsA) and hidradenitis suppurativa (HS), among others. The medication works as an interleukin 17 (IL-17) antagonist to lower inflammation in the body. It's usually injected under the skin once a month. You use the prefilled syringes, Sensoready Pens, or UnoReady Pens to inject. For some conditions, it can also be given as an infusion into the vein at a clinic. The dosing depends on your age, health condition, and treatment plan. Side effects can include upper respiratory tract infections and upset stomach. Cosentyx (secukinumab) is a brand-name medication.
Indications of Rinvoq vs. Cosentyx
Indications for
Moderate-to-severe inflammatory conditions in which other treatments haven't worked: